
Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease
Author(s) -
Kazuo Maeda
Publication year - 2019
Publication title -
women health care and issues
Language(s) - English
Resource type - Journals
ISSN - 2642-9756
DOI - 10.31579/2642-9756/009
Subject(s) - choriocarcinoma , methotrexate , medicine , chorioepithelioma , chemotherapy , disease , gynecology , trophoblastic neoplasm , obstetrics , oncology , pregnancy , gestation , biology , genetics
Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.